TRAIL Gene Polymorphism in Patients with Systemic Lupus Erythematosus

WANG Piming,ZHAO Peiqing,XU Liyun,LIU Bing,YAN Xiaohua,LIU Peng,GAO Lifen
DOI: https://doi.org/10.13431/j.cnki.immunol.j.20100187
2010-01-01
Abstract:In this paper,we aim to explore the association of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) single nucleotide polymorphism (SNP) with systemic lupus erythematosus (SLE) in Chinese Han nationality from Shandong province. This study followed a case-control design. According to American Rheumatism Association diagnostic criteria,167 patients with SLE and 190 healthy controls were included. The SNPs of TRAIL gene at 1525G/A and 1595C/T were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP),while genotype and allele frequencies were analyzed with Chi-square test. We found that genotype frequencies of 1525GG/1595CC,1525GA/1595CT,1525AA/1595TT were 23.3%,54.6%,22.1% in healthy controls and 35.3%,50.3%,14.4% in SLE patients respectively. Furthermore,there were significant differences in TRAIL genotype and allele frequencies between SLE patients and healthy controls. The results indicate that the presence of the GG/CC genotype of TRAIL at position 1525/1595 in exon 5 may represent a higher risk of SLE.
What problem does this paper attempt to address?